Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
9
11
2021
Statut:
epublish
Résumé
The global prevalence of chronic obstructive pulmonary disease (COPD) has increased markedly in recent decades. Given the scarcity of resources available to address global health challenges and respiratory medicine being relatively under-invested in, it is important to define research priorities for COPD globally. In this paper, we aim to identify a ranked set of COPD research priorities that need to be addressed in the next 10 years to substantially reduce the global impact of COPD. We adapted the Child Health and Nutrition Research Initiative (CHNRI) methodology to identify global COPD research priorities. 62 experts contributed 230 research ideas, which were scored by 34 researchers according to six pre-defined criteria: answerability, effectiveness, feasibility, deliverability, burden reduction, and equity. The top-ranked research priority was the need for new effective strategies to support smoking cessation. Of the top 20 overall research priorities, six were focused on feasible and cost-effective pulmonary rehabilitation delivery and access, particularly in primary/community care and low-resource settings. Three of the top 10 overall priorities called for research on improved screening and accurate diagnostic methods for COPD in low-resource primary care settings. Further ideas that drew support involved a better understanding of risk factors for COPD, development of effective training programmes for health workers and physicians in low resource settings, and evaluation of novel interventions to encourage physical activity. The experts agreed that the most pressing feasible research questions to address in the next decade for COPD reduction were on prevention, diagnosis and rehabilitation of COPD, especially in low resource settings. The largest gains should be expected in low- and middle-income countries (LMIC) settings, as the large majority of COPD deaths occur in those settings. Research priorities identified by this systematic international process should inform and motivate policymakers, funders, and researchers to support and conduct research to reduce the global burden of COPD.
Sections du résumé
BACKGROUND
BACKGROUND
The global prevalence of chronic obstructive pulmonary disease (COPD) has increased markedly in recent decades. Given the scarcity of resources available to address global health challenges and respiratory medicine being relatively under-invested in, it is important to define research priorities for COPD globally. In this paper, we aim to identify a ranked set of COPD research priorities that need to be addressed in the next 10 years to substantially reduce the global impact of COPD.
METHODS
METHODS
We adapted the Child Health and Nutrition Research Initiative (CHNRI) methodology to identify global COPD research priorities.
RESULTS
RESULTS
62 experts contributed 230 research ideas, which were scored by 34 researchers according to six pre-defined criteria: answerability, effectiveness, feasibility, deliverability, burden reduction, and equity. The top-ranked research priority was the need for new effective strategies to support smoking cessation. Of the top 20 overall research priorities, six were focused on feasible and cost-effective pulmonary rehabilitation delivery and access, particularly in primary/community care and low-resource settings. Three of the top 10 overall priorities called for research on improved screening and accurate diagnostic methods for COPD in low-resource primary care settings. Further ideas that drew support involved a better understanding of risk factors for COPD, development of effective training programmes for health workers and physicians in low resource settings, and evaluation of novel interventions to encourage physical activity.
CONCLUSIONS
CONCLUSIONS
The experts agreed that the most pressing feasible research questions to address in the next decade for COPD reduction were on prevention, diagnosis and rehabilitation of COPD, especially in low resource settings. The largest gains should be expected in low- and middle-income countries (LMIC) settings, as the large majority of COPD deaths occur in those settings. Research priorities identified by this systematic international process should inform and motivate policymakers, funders, and researchers to support and conduct research to reduce the global burden of COPD.
Identifiants
pubmed: 34737870
doi: 10.7189/jogh.11.15003
pii: jogh-11-15003
pmc: PMC8542376
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15003Subventions
Organisme : Medical Research Council
ID : G1001372
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N02995X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Informations de copyright
Copyright © 2021 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest. Igor Rudan and Harry Campbell are the Co-Editor in Chief of the Journal of Global Health. To ensure that any possible conflict of interest relevant to the journal has been addressed, this article was reviewed according to best practice guidelines of international editorial organisations.
Références
Lancet. 2017 May 13;389(10082):1931-1940
pubmed: 28513453
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Nature. 2011 Jul 06;475(7354):27-30
pubmed: 21734685
J Glob Health. 2015 Dec;5(2):020415
pubmed: 26755942
Lancet. 2012 Apr 7;379(9823):1341-51
pubmed: 22314182
Chest. 2021 Feb;159(2):575-584
pubmed: 33038390
Respir Res. 2019 Dec 21;20(1):291
pubmed: 31864411
COPD. 2019 Dec;16(5-6):311-320
pubmed: 31576763
Lancet Infect Dis. 2007 Jan;7(1):56-61
pubmed: 17182344
BMJ Open. 2012 Nov 19;2(6):
pubmed: 23166130
Prim Care Respir J. 2012 Mar;21(1):19-27
pubmed: 22273628
Am J Respir Crit Care Med. 2013 Feb 1;187(3):320-6
pubmed: 23155144
Lancet Respir Med. 2015 Feb;3(2):159-170
pubmed: 25680912
Science. 2003 Oct 17;302(5644):398-9
pubmed: 14563993
J Glob Health. 2016 Jun;6(1):010502
pubmed: 27350873
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Croat Med J. 2008 Dec;49(6):720-33
pubmed: 19090596
J Glob Health. 2016 Jun;6(1):010301
pubmed: 26401269
Eur Respir Rev. 2015 Jun;24(136):159-72
pubmed: 26028628
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Respirology. 2017 Apr;22(3):575-601
pubmed: 28150362
Nature. 2007 Nov 22;450(7169):494-6
pubmed: 18033288
J Glob Health. 2016 Jun;6(1):010508
pubmed: 26401272
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
J Glob Health. 2016 Jun;6(1):010503
pubmed: 27350874
COPD. 2021 Apr;18(2):133-146
pubmed: 33779454
Eur Respir J. 2019 Sep 5;54(3):
pubmed: 31488589
JMIR Res Protoc. 2015 Aug 12;4(3):e103
pubmed: 26268741
Public Health. 2012 Mar;126(3):237-240
pubmed: 22325672
Thorax. 2007 Jan;62(1):5-7
pubmed: 17189530
Health Expect. 2005 Sep;8(3):253-63
pubmed: 16098155
J Glob Health. 2016 Jun;6(1):010303
pubmed: 27303649
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32817205
J Glob Health. 2016 Jun;6(1):010501
pubmed: 27418959
BMC Med. 2015 Jul 02;13:157
pubmed: 26137986
J Glob Health. 2017 Jun;7(1):011004
pubmed: 28685049
Am J Respir Crit Care Med. 2018 Feb 1;197(3):289-299
pubmed: 29388824
Bull World Health Organ. 2009 Jun;87(6):438-46
pubmed: 19565122
Lancet. 2009 Nov 28;374(9704):1857-62
pubmed: 19944866
J Glob Health. 2019 Jun;9(1):010422
pubmed: 30842883
Thorax. 2019 Aug;74(8):727-729
pubmed: 31285362
Lancet Respir Med. 2020 Aug;8(8):e67-e68
pubmed: 32763207
J Glob Health. 2016 Jun;6(1):010302
pubmed: 27350870
Lancet Neurol. 2016 Nov;15(12):1285-1294
pubmed: 27751558
Int J Chron Obstruct Pulmon Dis. 2012;7:457-94
pubmed: 22927753